New Publication: Life Sciences India 2025: Law and Practice

Chambers & Partners Global Practice Guide Offering Comparative Analysis

The life sciences sector in India is rapidly evolving, driven by advances in technology, shifting public health priorities, and increasing global integration. As one of the most heavily regulated industries, the pharmaceutical and medical devices ecosystem in India is governed by a combination of laws and compliance requirements. Understanding this regulatory landscape is crucial for businesses, regulators, healthcare professionals, and investors navigating the Indian market.

Drawing on its life sciences law experience, NDA contributes to the India chapter to the Chambers Life Sciences Guide 2025 to help stakeholders better understand the country’s complex regulatory framework.

The guide offers in-depth analysis of India’s legal and regulatory framework across the product lifecycle, from R&D and clinical trials to marketing, manufacturing, distribution, and pricing. It also covers data protection, post-marketing obligations, regulatory reliance mechanisms, and recent legislative developments. Designed as a practical reference, the chapter provides critical insights into licensing processes, fast-track pathways, public procurement, and market access challenges in India’s dynamic life sciences ecosystem.

Please click here to access our paper.

Regards,

Uttara Jhaveri, Tanya Kukade, Eshika Phadke and Dr. Milind Antani

For any help or assistance, please email us on concierge@nishithdesai.com.

Do visit us at www.nishithdesai.com.

Disclaimer

The contents of this hotline should not be construed as legal opinion. View detailed disclaimer.

This hotline does not constitute a legal opinion and may contain information generated using various artificial intelligence (AI) tools or assistants, including but not limited to our in-house tool, NaiDA. We strive to ensure the highest quality and accuracy of our content and services. Nishith Desai Associates is committed to the responsible use of AI tools, maintaining client confidentiality, and adhering to strict data protection policies to safeguard your information.

This hotline provides general information existing at the time of preparation. The Hotline is intended as a news update and Nishith Desai Associates neither assumes nor accepts any responsibility for any loss arising to any person acting or refraining from acting as a result of any material contained in this Hotline. It is recommended that professional advice be taken based on the specific facts and circumstances. This hotline does not substitute the need to refer to the original pronouncements.

This is not a spam email. You have received this email because you have either requested for it or someone must have suggested your name. Since India has no anti-spamming law, we refer to the US directive, which states that a email cannot be considered spam if it contains the sender’s contact information, which this email does. In case this email doesn’t concern you, please unsubscribe from mailing list.